Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 323 M308 M317 M318 M 1.27 B Research & development ———— — Operating income 257 M283 M230 M263 M 1.03 B Non-Operating Income, Total 3 M-2 M4 M8 M 13 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 0000 0 Unusual income/expense 3 M-2 M4 M8 M 13 M Pretax income 216 M233 M187 M226 M 862 M Equity in earnings ———— — Taxes -55 M58 M-13 M21 M 11 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 271 M175 M200 M205 M 851 M Discontinued operations ———— — Net income 271 M175 M200 M205 M 851 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 271 M175 M200 M205 M 851 M Basic earnings per share (Basic EPS) 2.171.421.641.69 6.92 Diluted earnings per share (Diluted EPS) 2.161.421.631.69 6.9 Average basic shares outstanding 124.11 M122.66 M121.09 M122.07 M — Diluted shares outstanding 124.48 M122.88 M121.35 M122.38 M — EBITDA 297 M324 M270 M305 M 1.2 B EBIT 257 M283 M230 M263 M 1.03 B Cost of revenue 1.42 B1.34 B1.26 B1.28 B 5.3 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 40 M41 M40 M42 M 163 M